ESSILORLUXOTTICA Board Backs CEO Milleri After Press Reports
The eyewear group's board says it unanimously supports Chairman and CEO Francesco Milleri, his deputy and the approved strategy following recent media reports.
The eyewear group's board says it unanimously supports Chairman and CEO Francesco Milleri, his deputy and the approved strategy following recent media reports.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.